Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sinead Toomey, Stephen F. Madden, Simon J. Furney, Yue Fan, Mark McCormack, Carragh Stapleton, Mattia Cremona, Gianpiero L. Cavalleri, Malgorzata Milewska, Naomi Elster, Aoife Carr, Joanna Fay, Elaine W. Kay, Susan Kennedy, John Crown, William M. Gallagher, Bryan T. Hennessy, Alex J. Eustace
Published Oct 20, 2016 · Vol. 7, No. 46 · pp. 75518-75525
Eliza Tsitoura, Athol U. Wells, Kostantinos Karagiannis, Ismini Lasithiotaki, Eirini Vasarmidi, Eleni Bibaki, Chara Koutoulaki, Hiroe Sato, Demetrios A. Spandidos, Nikolaos M. Siafakas, George Sourvinos, Katerina M. Antoniou
Published Oct 18, 2016 · Vol. 7, No. 46 · pp. 74569-74581
Amber A. Bokhari, Laura R. Lee, Dewayne Raboteau, Jane Turbov, Isabel V. Rodriguez, John Wesley Pike, Chad A. Hamilton, George Larry Maxwell, Gustavo C. Rodriguez, Viqar Syed
Published Oct 18, 2016 · Vol. 7, No. 47 · pp. 77576-77590